Indole-based allosteric inhibitors of HIV-1 integrase
- PMID: 27568085
- PMCID: PMC5018460
- DOI: 10.1016/j.bmcl.2016.08.037
Indole-based allosteric inhibitors of HIV-1 integrase
Abstract
Employing a scaffold hopping approach, a series of allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) have been synthesized based on an indole scaffold. These compounds incorporate the key elements utilized in quinoline-based ALLINIs for binding to the IN dimer interface at the principal LEDGF/p75 binding pocket. The most potent of these compounds displayed good activity in the LEDGF/p75 dependent integration assay (IC50=4.5μM) and, as predicted based on the geometry of the five- versus six-membered ring, retained activity against the A128T IN mutant that confers resistance to many quinoline-based ALLINIs.
Keywords: ALLINI; HIV integrase inhibitor; Scaffold hopping.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures






Similar articles
-
Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors.Viruses. 2024 Jan 28;16(2):200. doi: 10.3390/v16020200. Viruses. 2024. PMID: 38399977 Free PMC article. Review.
-
The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors.J Biol Chem. 2013 May 31;288(22):15813-20. doi: 10.1074/jbc.M112.443390. Epub 2013 Apr 24. J Biol Chem. 2013. PMID: 23615903 Free PMC article.
-
A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.J Biol Chem. 2016 Nov 4;291(45):23569-23577. doi: 10.1074/jbc.M116.753384. Epub 2016 Sep 19. J Biol Chem. 2016. PMID: 27645997 Free PMC article.
-
The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.ACS Chem Biol. 2016 May 20;11(5):1313-21. doi: 10.1021/acschembio.6b00167. Epub 2016 Mar 2. ACS Chem Biol. 2016. PMID: 26910179 Free PMC article.
-
Allosteric inhibition of HIV-1 integrase activity.Curr Opin Chem Biol. 2013 Jun;17(3):339-45. doi: 10.1016/j.cbpa.2013.04.010. Epub 2013 May 3. Curr Opin Chem Biol. 2013. PMID: 23647983 Free PMC article. Review.
Cited by
-
Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors.Viruses. 2024 Jan 28;16(2):200. doi: 10.3390/v16020200. Viruses. 2024. PMID: 38399977 Free PMC article. Review.
-
Retroviral integrase: Structure, mechanism, and inhibition.Enzymes. 2021;50:249-300. doi: 10.1016/bs.enz.2021.06.007. Epub 2021 Aug 23. Enzymes. 2021. PMID: 34861940 Free PMC article.
-
Dihydroxyphenyl- and Heteroaromatic-Based Thienopyrimidinones to Tackle HIV-1 LEDGF/p75-Dependent IN Activity.Molecules. 2023 Sep 19;28(18):6700. doi: 10.3390/molecules28186700. Molecules. 2023. PMID: 37764476 Free PMC article.
-
New targets for HIV drug discovery.Drug Discov Today. 2019 May;24(5):1139-1147. doi: 10.1016/j.drudis.2019.03.013. Epub 2019 Mar 15. Drug Discov Today. 2019. PMID: 30885676 Free PMC article. Review.
-
A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF/p75-integrase interaction site.PLoS Pathog. 2021 Jul 22;17(7):e1009671. doi: 10.1371/journal.ppat.1009671. eCollection 2021 Jul. PLoS Pathog. 2021. PMID: 34293041 Free PMC article.
References
-
- Summa V, Petrocchi A, Bonelli F, Crescenzi B, Donghi M, Ferrara M, Fiore F, Gardelli C, Paz OG, Hazuda DJ, Jones P, Kinzel O, Laufer R, Monteagudo E, Muraglia E, Nizi E, Orvieto F, Pace P, Pescatore G, Scarpelli R, Stillmock K, Witmer MV, Rowley M. J. Med. Chem. 2008;51:5843. - PubMed
-
- Bailly F, Cotelle P. Expert Opin. Drug Discov. 2015;10:1243. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials